Jan Stern Reed - 20 Jul 2022 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role
Director
Signature
/s/ Richard C. Rosenzweig, Attorney in Fact
Issuer symbol
ANGO
Transactions as of
20 Jul 2022
Net transactions value
$0
Form type
4
Filing time
22 Jul 2022, 18:06:57 UTC
Previous filing
28 Apr 2022
Next filing
14 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANGO Common Stock Award $0 +7,060 +17% $0.000000 49,777 20 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The acquisition of 7,060 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 7,060 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/20/2023.